Jonathan D Kurtis Selected Research

Schistosomiasis japonica

1/2021	Whole-Proteome Differential Screening Identifies Novel Vaccine Candidates for Schistosomiasis japonica.
1/2021	Effect of maternal praziquantel treatment for Schistosoma japonicum infection on the offspring susceptibility and immunologic response to infection at age six, a cohort study.
1/2017	Vaccination with recombinant paramyosin in Montanide ISA206 protects against Schistosoma japonicum infection in water buffalo.
2/2014	Schistosomiasis japonica during pregnancy is associated with elevated endotoxin levels in maternal and placental compartments.
5/2009	Immunoglobulin E (IgE) responses to paramyosin predict resistance to reinfection with Schistosoma japonicum and are attenuated by IgG4.
7/2008	Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica.
10/2006	Pro-inflammatory cytokines and C-reactive protein are associated with undernutrition in the context of Schistosoma japonicum infection.
2/2006	Schistosomiasis japonica, anemia, and iron status in children, adolescents, and young adults in Leyte, Philippines 1.
8/2004	Expression, purification, and human antibody response to a 67 kDa vaccine candidate for schistosomiasis japonica.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jonathan D Kurtis Research Topics

Disease

24	Malaria 10/2021 - 10/2002
20	Infections 01/2021 - 07/2003
17	Schistosomiasis (Bilharziasis) 01/2021 - 08/2004
14	Anemia 01/2021 - 10/2002
11	Reinfection 01/2021 - 09/2005
9	Schistosomiasis japonica 01/2021 - 08/2004
7	Parasitemia 01/2021 - 08/2003
6	Iron Deficiencies 01/2021 - 02/2006
6	Inflammation (Inflammations) 01/2018 - 08/2005
4	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 01/2019 - 11/2006
4	Birth Weight (Birth Weights) 12/2016 - 04/2008
3	Hookworm Infections (Hookworm Infection) 01/2019 - 08/2010
3	Fibrosis (Cirrhosis) 01/2014 - 08/2005
2	Neoplasms (Cancer) 10/2021 - 01/2014
2	Communicable Diseases (Infectious Diseases) 01/2019 - 10/2009
2	Pregnancy Complications 01/2019 - 01/2014
2	Premature Birth (Birth, Premature) 02/2014 - 01/2014
2	Malnutrition (Nutritional Deficiencies) 10/2006 - 08/2005
1	Burkitt Lymphoma (Burkitt's Lymphoma) 10/2021
1	Thalassemia 01/2021
1	Idiopathic Pulmonary Fibrosis 11/2016
1	Idiopathic Interstitial Pneumonias 11/2016
1	Fever (Fevers) 02/2016
1	Headache (Headaches) 02/2016
1	Anaphylaxis (Anaphylactic Shock) 01/2016
1	Rupture 05/2014
1	Chorioamnionitis 02/2014
1	Liver Diseases (Liver Disease) 03/2011
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 03/2011
1	Cysticercosis 01/2010
1	Cognitive Dysfunction 10/2009

Drug/Important Bio-Agent (IBA)

21	CytokinesIBA 10/2021 - 10/2002
13	VaccinesIBA 01/2021 - 08/2004
12	AntigensIBA 10/2021 - 05/2009
12	Praziquantel (Biltricide)FDA Link 01/2021 - 01/2006
12	Hemoglobins (Hemoglobin)IBA 01/2019 - 07/2003
11	IronIBA 01/2021 - 02/2006
10	AntibodiesIBA 01/2021 - 08/2004
7	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 10/2017 - 10/2002
6	Interleukin-10 (Interleukin 10)IBA 10/2021 - 01/2008
4	Immunoglobulin G (IgG)IBA 01/2021 - 08/2004
4	Interleukin-6 (Interleukin 6)IBA 01/2021 - 10/2002
4	N-nitrosoiminodiacetic acidIBA 01/2019 - 11/2006
4	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2008
4	TropomyosinIBA 01/2017 - 07/2008
3	InterferonsIBA 10/2021 - 10/2002
3	Interleukin-1 (Interleukin 1)IBA 01/2021 - 08/2005
3	ProteomeIBA 01/2021 - 10/2018
3	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2014
3	HepcidinsIBA 01/2019 - 10/2016
3	Interferon-gamma (Interferon, gamma)IBA 09/2012 - 10/2002
2	Interleukin-13IBA 01/2021 - 01/2006
2	Interleukin-4 (Interleukin 4)IBA 01/2021 - 01/2006
2	Immunoglobulin E (IgE)IBA 01/2021 - 05/2009
2	Interleukin-12 (IL 12)IBA 01/2021 - 01/2006
2	Ferritins (Ferritin)IBA 01/2018 - 04/2008
2	EndotoxinsIBA 01/2018 - 02/2014
2	ChemokinesIBA 10/2017 - 09/2012
2	CollagenIBA 01/2014 - 03/2011
2	LigandsIBA 09/2012 - 11/2010
2	C-Reactive ProteinIBA 10/2006 - 08/2005
2	Dehydroepiandrosterone SulfateIBA 06/2006 - 07/2003
2	Immunoglobulins (Immunoglobulin)IBA 09/2005 - 06/2005
2	InterleukinsIBA 08/2005 - 10/2002
1	Viral ProteinsIBA 10/2021
1	Interleukin-17 (Interleukin 17)IBA 10/2021
1	Interleukin-5 (Interleukin 5)IBA 01/2021
1	Erythropoietin FDA Link 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Surface Antigens (Surface Antigen)IBA 03/2018
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2018
1	EpitopesIBA 07/2017
1	Monatide (IMS 3015)IBA 01/2017
1	OsteopontinIBA 11/2016
1	Matrix Metalloproteinase 7 (Matrilysin)IBA 11/2016
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 11/2016
1	antineoplaston A10 (A 10)IBA 01/2016
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2014
1	procollagen type I carboxy terminal peptide (PICP)IBA 01/2014
1	Insulin-Like PeptidesIBA 01/2014
1	DesmosineIBA 01/2014
1	ProcollagenIBA 01/2014
1	Tissue Inhibitor of MetalloproteinasesIBA 01/2014
1	Matrix Metalloproteinases (MMPs)IBA 01/2014
1	Collagen Type I (Type I Collagen)IBA 01/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2014
1	Connective Tissue Growth FactorIBA 01/2014
1	P 11 (P-11)IBA 04/2012
1	Indicators and Reagents (Reagents)IBA 01/2012
1	Metalloproteases (Metalloproteinases)IBA 03/2011
1	Tissue Inhibitor of Metalloproteinase-1IBA 03/2011
1	Plasmodium falciparum erythrocyte membrane protein 1IBA 11/2010
1	Synthetic Vaccines (Recombinant Vaccines)IBA 05/2009
1	Immunoglobulin A (IgA)IBA 05/2009
1	Folic Acid (Vitamin M)FDA LinkGeneric 07/2008
1	LeptinIBA 04/2008
1	Messenger RNA (mRNA)IBA 01/2008

Therapy/Procedure

6	Aftercare (After-Treatment) 07/2008 - 08/2005
4	Drug Therapy (Chemotherapy) 01/2021 - 01/2006
2	Therapeutics 11/2006 - 06/2005